SCHEMBL1343465

SCHEMBL1343465

N#Cc1ccc2ccc3ccccc3c2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.69
CA2 P00918 3/20 0.69
ALDH1A1 P00352 5/20 0.56
HSD17B10 Q99714 3/20 0.56
CYP1B1 Q16678 2/20 0.56
HIF1A Q16665 1/20 0.56
TSHR P16473 2/20 0.52
CYP2A6 P11509 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
KDM4E B2RXH2 2/20 0.49
CYP1A2 P05177 2/20 0.48
CYP1A1 P04798 1/20 0.48
HPRT1 P00492 1/20 0.48
HPGD P15428 2/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
ITK Q08881 1/20 0.42
PDPK1 O15530 1/20 0.42
AR P10275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3632654 0.96 CA1 (0.65) CA1CA2ALDH1A1HSD17B10CYP1B1
SCHEMBL29131409 0.96 CA1 (0.65) CA1CA2ALDH1A1HSD17B10CYP1B1
SCHEMBL1344052 0.89 CA1 (0.67) CA1CA2ALDH1A1HSD17B10CYP1B1
SCHEMBL13037655 0.89 CA2 (0.57) CA1CA2ALDH1A1TSHRCYP2A6
SCHEMBL12310187 0.88 CA1 (0.65) CA1CA2ALDH1A1HSD17B10CYP1B1
SCHEMBL12320895 0.88 CA1 (0.65) CA1CA2ALDH1A1HSD17B10CYP1B1
SCHEMBL3634628 0.85 CA1 (0.53) CA1CA2ALDH1A1HSD17B10CYP1B1
SCHEMBL28174467 0.84 CA1 (0.50) CA1CA2ALDH1A1HSD17B10CYP1B1
SCHEMBL11210283 0.84 CA1 (0.71) CA1CA2ALDH1A1KDM4ECYP1A2
SCHEMBL30462444 0.82 CA1 (0.54) CA1CA2ALDH1A1HSD17B10CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1318422-C Substituted pyrazolopyrimidines and thiazolopyrimidines GRSENENTHAL GMBH (DE) 2007-05-30 CN claimed
CN-1507447-A Substituted pyrazolopyrimidines and thiazolopyrimidines 2004-06-23 CN claimed
CN-119039149-A Method for preparing aromatic methylamine 鞍山七彩化学股份有限公司 2024-11-29 CN disclosed
US-8062429-B2 Methods of cleaning semiconductor devices at the back end of line using amidoxime compositions EKC TECHNOLOGY, INC. (US) 2011-11-22 US disclosed
US-20100105595-A1 COMPOSITION COMPRISING CHELATING AGENTS CONTAINING AMIDOXIME COMPOUNDS EKC TECHNOLOGY, INC. 2010-04-29 US disclosed
US-20100043823-A1 METHODS OF CLEANING SEMICONDUCTOR DEVICES AT THE BACK END OF LINE USING AMIDOXIME COMOSITIONS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2010-02-25 US disclosed
WO-2009085072-A1 COMPOSITION COMPRISING CHELATING AGENTS CONTAINING AMIDOXIME COMPOUNDS EKC TECHNOLOGY, INC (US) 2009-07-09 WO disclosed
US-20090137191-A1 COPPER CMP POLISHING PAD CLEANING COMPOSITION COMPRISING OF AMIDOXIME COMPOUNDS EKC TECHNOLOGY, INC. 2009-05-28 US disclosed
US-20090133716-A1 METHODS OF POST CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING USING AMIDOXIME COMPOSITIONS EKC TECHNOLOGY, INC. 2009-05-28 US disclosed
US-20090130849-A1 CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING COMPOSITION COMPRISING AMIDOXIME COMPOUNDS AND ASSOCIATED METHOD FOR USE EKC TECHNOLOGY, INC. 2009-05-21 US disclosed
WO-2009058274-A1 CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING COMPOSITION COMPRISING AMIDOXIME COMPOUNDS AND ASSOCIATED METHOD FOR USE EKC TECHNOLOGY, INC. (US) 2009-05-07 WO disclosed
WO-2009058275-A1 METHODS OF POST CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING USING AMIDOXIME COMPOSITIONS EKC TECHNOLOGY, INC. (US) 2009-05-07 WO disclosed
WO-2009058288-A1 AMIDOXIME COMPOUNDS AS CHELATING AGENTS IN SEMICONDUCTOR PROCESSES EKC TECHNOLOGY, INC. (US) 2009-05-07 WO disclosed
WO-2009058278-A1 METHODS OF CLEANING SEMICONDUCTOR DEVICES AT THE BACK END OF LINE USING AMIDOXIME COMPOSITIONS EKC TECHNOLOGY, INC (US) 2009-05-07 WO disclosed
US-20090107520-A1 AMIDOXIME COMPOUNDS AS CHELATING AGENTS IN SEMICONDUCTOR PROCESSES EKC TECHNOLOGY, INC. 2009-04-30 US disclosed
CN-1318422-C Substituted pyrazolopyrimidines and thiazolopyrimidines GRSENENTHAL GMBH (DE) 2007-05-30 CN disclosed
CN-1507447-A Substituted pyrazolopyrimidines and thiazolopyrimidines 2004-06-23 CN disclosed
US-5780250-A Immunoassay standards for polyaromatic hydrocarbon detection STRATEGIC DIAGNOSTICS, INC. (US) 1998-07-14 US disclosed
WO-1997031267-A1 IMMUNOASSAY STANDARDS FOR POLYAROMATIC HYDROCARBON DETECTION STRATEGIC DIAGNOSTICS, INC. (US) 1997-08-28 WO disclosed
EP-0705250-A1 BIS-IMIDE POLYCYCLIC AND HETEROCYCLIC CHROMOPHORES USEFUL AS TUMORICIDALS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-04-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137191-A1 COPPER CMP POLISHING PAD CLEANING COMPOSITION COMPRISING OF AMIDOXIME COMPOUNDS PADI2, PADI4, PADI3 CA1 952/4885CA2 2808/4885ALDH1A1 3030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.